Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Biotech

Why Corxel picked SPAC route to take obesity biotech public

Corxel may not have always planned to dust off the SPAC route to the public markets, but the obesity-focused biotech is happy with its choice.

Marissa Russo Oct 27, 2026 6:00am

Novartis CEO keeps faith in Avidity despite $1.9B hit from fail

Oct 27, 2026 3:48am

How AI is reshaping biopharma decision-making

Brought to you by Clarivate

GSK’s B7-H3 ADC drives 67% cancer risk reduction in phase 3

Oct 27, 2026 3:28am

Biotech value creation at an inflection point

Brought to you by Lumanity

Anthropic details drug R&D ambitions, risks in IPO filing

Oct 26, 2026 2:00pm